NIVABUPA Niva Bupa Health Insurance Company Q1 FY26 results (Apr–Jun 2025) and concall
Niva Bupa Health reported a strong quarter of top-line growth, with GWP up 28% on a comparable basis, led by its core retail segment. IFRS profitability showed significant improvement, nearly doubling year-over-year. However, the quarter was marked by two key issues: significant distortion in I-GAAP financials due to new accounting rules for multi-year policies, and a temporary operational halt in claims auto-adjudication. This halt impacted service levels and necessitated higher reserving, which inflated the reported loss ratio for the quarter. Management emphasized that IFRS financials are a
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 1,321 | 1,258 | 1,671 | 1,932 |
| EBITDA | -66 | -24 | 251 | 98 |
| Net profit | 13 | 13 | 206 | 71 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
